Blueprint Medicines Corp
BPMCDelisted Jul 18, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597264
Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding Blueprint Medicines Corp changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 222 | 3 | 220 | +1 |
| Shares | 63.8M | 729.4K | 64.7M | +1.61M (+2.5%) |
| Value | $4.03B | $46.1M | $3.25B | −$734.1M (−18.4%) |
3 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (27)
Institutions that held Blueprint Medicines Corp at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (26)
Institutions that held Blueprint Medicines Corp at the end of Q2 2023 and filed for Q3 2023 without it.
Not filed for Q3 2023 yet (3)
Institutions that held Blueprint Medicines Corp at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 723,766 | $45.7M |
| Efg Capital International Corp. | 5,500 | $347.6K |
| Kistler-Tiffany Companies, LLC | 100 | $6.32K |